Micardis

Top 10 Drug Patent Losses of 2014
Fierce Pharma
Mon, 10/28/13 - 10:26 am
patents
Copaxone
Teva
Nexium
AstraZeneca
Micardis
Boehringer Ingelheim
Sandostatin LAR
Novartis
Exforge
Nasonex
Merck
TriLipix
AbbVie
Evista
Eli Lilly
Restasis
Allergan
Renagel
Sanofi
Drugmaker Boehringer settles marketing claim for $95 mln
Reuters
Thu, 10/25/12 - 05:35 pm
Boehringer Ingelheim
Aggrenox
off-label
Micardis
Combivent
Atrovent
FDA takes a closer look at possible cancer risks of widely used blood pressure medicines
Star Ledger, NJ
Fri, 07/16/10 - 09:26 am
FDA
cancer
ARBs
Merck
Cozaar
Bristol-Myers Squibb
Avapro
Atacand
Benicar
Diovan
Micardis
Teveten
Common Blood Pressure Pills Linked To Cancer
Forbes
Mon, 06/14/10 - 12:15 pm
cancer
ARBs
Benicar
Daiichi Sankyo
Micardis
Boehringer Ingelheim
Merck
Cozaar
Novartis
Diovan